Surgery first vs chemo then surgery for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two approaches for stomach cancer that has spread a bit but can still be removed with surgery. One group has surgery first, the other gets chemotherapy before surgery. The goal is to see which sequence leads to better long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your stomach cancer is at a locally advanced stage (T2 or deeper, or has spread to nearby lymph nodes) but not to distant organs.
- The cancer can be fully removed with surgery after a specific type of lymph node removal (D2).
- You are older than 18 years old.
- You have not had another cancer in the last 5 years (except for certain early skin or cervical cancers).
- Your cancer is not at the very top of the stomach (Siewert type I or II).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares giving chemotherapy before surgery versus going straight to surgery in older adults with stage III stomach (or where the esophagus meets the stomach) cancer. It’s meant to see which approach works better to control the cancer and improve outcomes.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial studies which surgical approach (removing lymph nodes in a more limited vs more extensive way) works best for gastric cancer after you’ve already started chemotherapy before surgery. It’s aimed at improving cancer control while keeping the operation as safe as possible.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
This trial compares two approaches for stomach cancer that has spread to the abdominal lining after initial treatment (conversion therapy). One group receives surgery to remove the cancer, while the other does not. The goal is to see if surgery improves outcomes in patients who responded well to the initial treatment.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.